HighVista Strategies »

Erasca shares owned by HighVista Strategies

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 181k 16.18
2025-03-31 $186k 136k 1.37
2024-12-31 $341k 136k 2.51

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Spyre Therapeutics Com New (SYRE)
Vaxcyte (PCVX)
Revolution Medicines (RVMD)
Terns Pharmaceuticals (TERN)
Structure Therapeutics Sponsored Ads (GPCR)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Soleno Therapeutics (SLNO)
Tyra Biosciences (TYRA)
Amylyx Pharmaceuticals (AMLX)
Amazon (AMZN)

View all positions for HighVista Strategies

Top funds holding Erasca

Frazier Life Sciences Management
BlackRock
VR Adviser
Rtw Investments
T. Rowe Price Investment Management
Vanguard Group
Vivo Capital
Vanguard Capital Management
Siren
Logos Global Management
Paradigm Biocapital Advisors
State Street Corporation
Arch Venture Corp
Geode Capital Management
Cormorant Asset Management

View all funds holding Erasca